Literature DB >> 1835119

Pulmonary hypertension in connective tissue disease. Report of three cases and review of the literature.

L C Pronk1, A J Swaak.   

Abstract

Patients with connective tissue disease (CTD) who are prone to developed isolated pulmonary hypertension (PH) are primarily young females with a history of Raynaud's phenomenon associated with an exertional dyspnoea. From the start of the disease, pulmonary function tests show a decreased diffusing capacity for carbon monoxide, while X-ray examination shows no obvious abnormalities such as interstitial fibrosis. All patients show, on electrocardiographic examination, evidence of right axis deviation and right ventricular hypertrophy. It has been suggested that PH is found mostly in patients with systemic scerlosis characterized by the CREST syndrome. The histopathological findings are intimal proliferation, narrowing of the vessel lumen and medial fibrosis. These are not specific for CTD. One would expect more signs of vasculitis. Neither signs of lung fibrosis, nor signs of pulmonary emboli are described.

Entities:  

Mesh:

Year:  1991        PMID: 1835119     DOI: 10.1007/bf00291151

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  12 in total

Review 1.  Cardiopulmonary manifestations of systemic sclerosis.

Authors:  G R Owens; W P Follansbee
Journal:  Chest       Date:  1987-01       Impact factor: 9.410

2.  Pulmonary hypertension and systemic lupus erythematosus.

Authors:  R A Asherson; C M Oakley
Journal:  J Rheumatol       Date:  1986-02       Impact factor: 4.666

3.  Pulmonary hypertension in systemic lupus erythematosus.

Authors:  R A Asherson; C G Mackworth-Young; M L Boey; R G Hull; A Saunders; A E Gharavi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

4.  Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus.

Authors:  F P Quismorio; O Sharma; M Koss; T Boylen; A W Edmiston; P J Thornton; D Tatter
Journal:  Semin Arthritis Rheum       Date:  1984-05       Impact factor: 5.532

5.  Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma.

Authors:  G R Owens; G J Fino; D L Herbert; V D Steen; T A Medsger; B E Pennock; J J Cottrell; G P Rodnan; R M Rogers
Journal:  Chest       Date:  1983-11       Impact factor: 9.410

6.  Pulmonary hypertension in systemic lupus erythematosus: a report of four cases.

Authors:  P Hodson; P Klemp; O L Meyers
Journal:  Clin Exp Rheumatol       Date:  1983 Jul-Sep       Impact factor: 4.473

7.  Pulmonary vascular changes in scleroderma.

Authors:  R H Young; G J Mark
Journal:  Am J Med       Date:  1978-06       Impact factor: 4.965

8.  Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis.

Authors:  A M Stupi; V D Steen; G R Owens; E L Barnes; G P Rodnan; T A Medsger
Journal:  Arthritis Rheum       Date:  1986-04

9.  Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma).

Authors:  R Salerni; G P Rodnan; D F Leon; J A Shaver
Journal:  Ann Intern Med       Date:  1977-04       Impact factor: 25.391

Review 10.  Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature.

Authors:  H D Perez; N Kramer
Journal:  Semin Arthritis Rheum       Date:  1981-08       Impact factor: 5.532

View more
  1 in total

1.  Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis.

Authors:  David A Zisman; David J Ross; John A Belperio; Rajan Saggar; Joseph P Lynch; Abbas Ardehali; Arun S Karlamangla
Journal:  Respir Med       Date:  2007-07-02       Impact factor: 3.415

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.